FAST vs MGRX · P/E 43, rev $4.59B vs rev $456.0K
Fastenal Company (FAST) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the FAST and MGRX stock pages for the full models.
Not investment advice.